Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach
Address
First Use Date
May 1, 2019
Filing Date
May 9, 2019
Registration Date
May 11, 2021
Goods
The mark consists of the words "Prednisolone PO4 / Bromfenac Ophthalmic Solution 1% / 0.075%" are above the words of "OMNI by OSRX". The "Prednisolone PO4 / Bromfenac Ophthalmic Solution" words are above the "1% / 0.075%" language. The word "OMNI" is above the words "by OSRX". The lettering for "OMNI" is larger than the lettering for "by OSRX". There is a shaded circle behind most of the letter "M" in "OMNI". There is a top arc that begins between the "O" and the "M" of "OMNI" and arcs towards the right ending to the right of the "I" in "OMNI" and ending to the right of the "X" in "OSRX". There is a bottom arc that begins at the "N" in "OMNI" and then arcs towards the left ending to the left of the "O" in "OMNI".
No documents found for this trademark.